Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
и још 1

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 21. 9. 2026. · NCT06021626

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 11. 9. 2026. · NCT06797999

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

New York University Langone Health, New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 8. 9. 2026. · NCT05732831

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 8. 9. 2026. · NCT04577014

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1

Узраст од 12 до 85 · Оба пола · Ажурирано 8. 9. 2026. · NCT03715933

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 4. 9. 2026. · NCT06644755

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

Montefiore Medical Center, The Bronx

Тражи се учесникФаза 1/2

Узраст од 12 до 40 · Оба пола · Ажурирано 3. 9. 2026. · NCT07725380

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
и још 1

Тражи се учесник

Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT05837767

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Roswell Park Cancer Institute, Buffalo

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 21. 8. 2026. · NCT03965234

Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

Memorial Sloan Kettering Commack (Consent and Follow-Up), Commack
Memorial Sloan Kettering Westchester (Consent and Followup), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
и још 1

Тражи се учесникОпсервациона студија

Сви узрасти · Оба пола · Ажурирано 30. 7. 2026. · NCT00579566

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
и још 1

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 28. 7. 2026. · NCT07089992

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

Zai Lab Site 02002, New York

Тражи се учесникФаза 1

Узраст 18 и старији · Оба пола · Ажурирано 23. 7. 2026. · NCT07374848

Integrated Cancer Repository for Cancer Research

C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
Faxton St. Luke's Healthcare, Mohawk Valley, Utica

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле

Узраст од 19 до 110 · Оба пола · Ажурирано 29. 6. 2026. · NCT02012699

Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All protocol activites), New York
и још 1

Тражи се учесник

Узраст 18 и старији · Оба пола · Ажурирано 15. 5. 2026. · NCT06129903

A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
и још 1

Тражи се учесникФаза 2

Узраст 12 и старији · Оба пола · Ажурирано 23. 4. 2026. · NCT04332874

Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study

Roswell Park Comprehensive Cancer Center, Buffalo

Тражи се учесникОпсервациона студија

Узраст од 12 до 70 · Оба пола · Ажурирано 15. 4. 2026. · NCT07402577

A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma

Memorial Sloan Kettering Cancer Centre, New York

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 12. 3. 2026. · NCT05755113

Phase II Trial of Lung Chemoemobolization

Memorial Sloan Kettering Cancer Center, New York

Тражи се учесникФаза 2

Узраст 18 и старији · Оба пола · Ажурирано 5. 3. 2026. · NCT05672108

Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
New York Medical Center/ Maria Fareri Children's Hospital, Valhalla

Тражи се учесникФаза 1/2

12 Months – 40 Years · Оба пола · Ажурирано 5. 2. 2026. · NCT03465592

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Children's Hospital at Montefiore, The Bronx

Тражи се учесникФаза 2

18 Months – 40 Years · Оба пола · Ажурирано 12. 8. 2025. · NCT05135975

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Memorial Sloan-Kettering Cancer Center, New York

Тражи се учесникФаза 1/2

Узраст 18 и старији · Оба пола · Ажурирано 25. 11. 2024. · NCT05824975

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.